Submit Deal

KNIGHT THERAPEUTICS INC

HQ - Montreal

Summary

Knight Therapeutics is a Montreal-based specialty pharmaceutical company that focuses on the acquisition, in-licensing, and commercialization of innovative pharmaceuticals.

Deals Overview

Total Deals3

Valued Deals3

Total Value£ 266 M

Avg. Deal Size£ 89 M

Market Context

Senior Management

Arvind Utchanah
CFO
Jonathan Ross Goodman
Chairman

Sort

21 Oct 2019|Brazil|Biotechnology

Target: BIOTOSCANA

Bidder: KNIGHT THERAPEUTICS INC

4 Service Providers

1 Target | 3 Bidder

2 Dealmakers

1 Target | 2 Bidder

£ 110 M

Value

11 Mar 2025|Canada|Pharmaceuticals

Target: PALADIN PHARMA INC

Bidder: KNIGHT THERAPEUTICS INC

6 Service Providers

3 Bidder | 3 Vendor

23 Dealmakers

3 Bidder | 20 Vendor

£ 77 M

Value

17 Jun 2025|Ireland|Pharmaceuticals

Target: ENDO (INTERNATIONAL PHARMACEUTICALS BUSINESS)

Bidder: KNIGHT THERAPEUTICS INC

2 Service Providers

1 Bidder | 1 Vendor

2 Dealmakers

1 Bidder | 1 Vendor

£ 77 M

Value